Bank of Nova Scotia lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 50.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,618 shares of the medical instruments supplier’s stock after selling 3,679 shares during the quarter. Bank of Nova Scotia’s holdings in Mettler-Toledo International were worth $4,563,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new position in Mettler-Toledo International during the fourth quarter worth $520,989,000. M&T Bank Corp grew its holdings in shares of Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after acquiring an additional 119,942 shares during the period. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Mettler-Toledo International by 39,107.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 61,556 shares of the medical instruments supplier’s stock worth $85,821,000 after purchasing an additional 61,399 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC grew its holdings in Mettler-Toledo International by 4,990.0% in the fourth quarter. Douglass Winthrop Advisors LLC now owns 48,253 shares of the medical instruments supplier’s stock valued at $67,274,000 after purchasing an additional 47,305 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes Several research analysts recently issued reports on the company. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Citigroup dropped their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Wolfe Research began coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,408.55.
Read Our Latest Research Report on Mettler-Toledo International
Mettler-Toledo International Stock Up 0.6% Shares of Mettler-Toledo International stock opened at $1,335.70 on Tuesday. The business has a 50-day moving average price of $1,212.30 and a 200 day moving average price of $1,276.84. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The firm has a market cap of $26.99 billion, a P/E ratio of 31.33, a P/E/G ratio of 2.77 and a beta of 1.24.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.63 earnings per share for the current year.
Mettler-Toledo International Company Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading Five stocks we like better than Mettler-Toledo International AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECarlisle Companies (CSL) Projected to Release Earnings on Wednesday
NEXT HEADLINE »Caxton Associates LLP Has $689,000 Stock Position in Reliance, Inc. $RS
Dimensional Fund Advisors LP grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 4.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 106,023 shares of the medical instruments supplier’s stock after purchasing an additional 4,340 shares during the period. Dimensional Fund Advisors LP owned about 0.52% of Mettler-Toledo International worth $133,712,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in MTD. Whipplewood Advisors LLC bought a new stake in shares of Mettler-Toledo International during the first quarter worth about $25,000. Reflection Asset Management acquired a new stake in Mettler-Toledo International during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth approximately $29,000. Root Financial Partners LLC grew its holdings in Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock worth $40,000 after acquiring an additional 10 shares during the last quarter. Finally, DV Equities LLC acquired a new position in Mettler-Toledo International in the 4th quarter valued at approximately $40,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Mettler-Toledo International Trading Up 0.6% Shares of Mettler-Toledo International stock opened at $1,335.70 on Tuesday. The business has a 50-day moving average price of $1,212.30 and a two-hundred day moving average price of $1,276.84. Mettler-Toledo International, Inc. has a 1-year low of $1,023.05 and a 1-year high of $1,525.17. The company has a market cap of $26.99 billion, a P/E ratio of 31.33, a PEG ratio of 2.77 and a beta of 1.24.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Equities research analysts forecast that Mettler-Toledo International, Inc. will post 46.63 EPS for the current fiscal year.
Wall Street Analyst Weigh In Several research firms have recently issued reports on MTD. Weiss Ratings downgraded shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, July 21st. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Morgan Stanley decreased their price objective on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Robert W. Baird cut their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Finally, Citigroup reduced their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $1,408.55.
Read Our Latest Analysis on Mettler-Toledo International
Mettler-Toledo International Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also Five stocks we like better than Mettler-Toledo International AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBoston Scientific (NYSE:BSX) Given New $85.00 Price Target at Oppenheimer
NEXT HEADLINE »Dimensional Fund Advisors LP Has $119.58 Million Position in Knife River Corporation $KNF
Mettler-Toledo (MTD - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 30. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis maker of precision instruments is expected to post quarterly earnings of $10.78 per share in its upcoming report, which represents a year-over-year change of +6.8%.
Revenues are expected to be $1.03 billion, up 5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Mettler-Toledo?For Mettler-Toledo, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination makes it difficult to conclusively predict that Mettler-Toledo will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Mettler-Toledo would post earnings of $8.7 per share when it actually produced earnings of $8.91, delivering a surprise of +2.41%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Mettler-Toledo doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Investors might want to bet on Mettler-Toledo (MTD - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Mettler-Toledo is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Mettler-Toledo imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Mettler-ToledoFor the fiscal year ending December 2026, this maker of precision instruments is expected to earn $46.63 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Mettler-Toledo. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.3%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Mettler-Toledo to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its second quarter 2026 financial results after the market close on Thursday, July 30, 2026. The Company will host a conference call the following morning at 7:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company’s website, investor.mt.com.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Mettler-Toledo (MTD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
On June 24, 2026, Mettler-Toledo International Inc (MTD) shares rose 4.0% to $1203.18, reflecting a positive shift in market sentiment. Despite today's move, th
Dimensional Fund Advisors LP decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 4.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 102,564 shares of the medical instruments supplier's stock after selling 5,160 shares during the period. Dimensional Fund Advisors LP
Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical instruments supplier's stock after acquiring an additional 616 shares
Nordea Investment Management AB increased its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 11.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 157,457 shares of the medical instruments supplier's stock after buying an additional 16,777 shares during the period. Nordea
Canoe Financial LP lessened its holdings in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,864 shares of the medical instruments supplier’s stock after selling 2,260 shares during the period. Canoe Financial LP owned about 0.26% of Mettler-Toledo International worth $75,097,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the business. Versant Capital Management Inc raised its stake in shares of Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. grew its stake in Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the period. Salomon & Ludwin LLC acquired a new stake in Mettler-Toledo International in the 3rd quarter valued at $43,000. Root Financial Partners LLC purchased a new stake in Mettler-Toledo International in the 3rd quarter worth $42,000. Finally, Quantbot Technologies LP acquired a new position in Mettler-Toledo International during the third quarter worth $49,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Insider Buying and Selling In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.94% of the company’s stock.
Analyst Upgrades and Downgrades Several analysts have recently issued reports on the stock. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research report on Monday, December 15th. Barclays reduced their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Finally, Morgan Stanley cut their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 10th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $1,463.75.
View Our Latest Analysis on MTD
Mettler-Toledo International Stock Down 2.8% Mettler-Toledo International stock opened at $1,234.22 on Friday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17. The firm has a market capitalization of $24.99 billion, a price-to-earnings ratio of 29.30, a PEG ratio of 2.58 and a beta of 1.43. The company has a fifty day simple moving average of $1,328.56 and a 200-day simple moving average of $1,364.02.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the firm posted $12.41 earnings per share. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
About Mettler-Toledo International (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading Five stocks we like better than Mettler-Toledo International Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
Aberdeen Group plc grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 16.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,756 shares of the medical instruments supplier’s stock after buying an additional 2,862 shares during the period. Aberdeen Group plc owned 0.10% of Mettler-Toledo International worth $28,938,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of MTD. Principal Financial Group Inc. boosted its position in shares of Mettler-Toledo International by 2.9% during the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock valued at $366,354,000 after acquiring an additional 8,360 shares during the last quarter. Nordea Investment Management AB increased its position in shares of Mettler-Toledo International by 11.9% in the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after purchasing an additional 16,777 shares during the last quarter. Corient Private Wealth LLC raised its stake in Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in Mettler-Toledo International during the third quarter valued at approximately $2,210,000. Finally, Rakuten Investment Management Inc. bought a new stake in Mettler-Toledo International during the third quarter valued at approximately $121,021,000. 95.07% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the transaction, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.94% of the stock is owned by insiders.
Mettler-Toledo International Price Performance NYSE MTD opened at $1,262.02 on Monday. The stock has a market capitalization of $25.56 billion, a PE ratio of 29.96, a PEG ratio of 2.64 and a beta of 1.43. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The business’s 50-day moving average is $1,311.78 and its 200 day moving average is $1,364.50.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the prior year, the company posted $12.41 EPS. Mettler-Toledo International’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Analyst Upgrades and Downgrades Several analysts have recently weighed in on the stock. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays lowered their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the stock from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Finally, The Goldman Sachs Group began coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International currently has an average rating of “Moderate Buy” and a consensus target price of $1,463.75.
Read Our Latest Analysis on MTD
About Mettler-Toledo International (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX
NEXT HEADLINE »Aberdeen Group plc Reduces Stock Holdings in Republic Services, Inc. $RSG
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading globa.
Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $1,463.75.
Several brokerages recently weighed in on MTD. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays cut their target price on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective on the stock in a research report on Monday, December 15th. Morgan Stanley dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th.
View Our Latest Analysis on MTD
Insider Activity In related news, CFO Shawn Vadala sold 800 shares of the stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.71% of the company’s stock.
Institutional Trading of Mettler-Toledo International Several hedge funds have recently made changes to their positions in MTD. Reflection Asset Management purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $29,000. Versant Capital Management Inc increased its holdings in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares in the last quarter. SJS Investment Consulting Inc. increased its holdings in Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares in the last quarter. Finally, DV Equities LLC purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Mettler-Toledo International Stock Up 0.6% MTD stock opened at $1,330.10 on Friday. The stock has a market capitalization of $26.93 billion, a P/E ratio of 31.58, a P/E/G ratio of 2.77 and a beta of 1.43. The firm has a 50-day simple moving average of $1,302.70 and a 200-day simple moving average of $1,363.84. Mettler-Toledo International has a 52 week low of $962.54 and a 52 week high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. Mettler-Toledo International’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the business posted $12.41 earnings per share. On average, analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.
Mettler-Toledo International Company Profile (Get Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINETexas Capital Government Money Market ETF (NYSEARCA:MMKT) Trading 0% Higher – What’s Next?
NEXT HEADLINE »STKD Bitcoin & Gold ETF (NYSEARCA:BTGD) Stock Price Up 1.7% – Here’s Why
Massachusetts Financial Services Co. MA reduced its holdings in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 167,872 shares of the medical instruments supplier’s stock after selling 13,995 shares during the period. Massachusetts Financial Services Co. MA owned about 0.82% of Mettler-Toledo International worth $234,045,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of MTD. Rakuten Investment Management Inc. acquired a new stake in Mettler-Toledo International in the third quarter valued at approximately $121,021,000. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 10.7% in the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the period. Corient Private Wealth LLC grew its holdings in Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares during the period. Thrivent Financial for Lutherans grew its holdings in Mettler-Toledo International by 752.2% in the third quarter. Thrivent Financial for Lutherans now owns 73,586 shares of the medical instruments supplier’s stock valued at $90,335,000 after purchasing an additional 64,951 shares during the period. Finally, Bank of America Corp DE grew its holdings in Mettler-Toledo International by 56.8% in the third quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock valued at $157,276,000 after purchasing an additional 46,402 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Mettler-Toledo International In related news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.71% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In Several brokerages have commented on MTD. Morgan Stanley dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price objective for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Finally, Barclays decreased their target price on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $1,463.75.
Check Out Our Latest Research Report on MTD
Mettler-Toledo International Price Performance NYSE MTD opened at $1,323.27 on Monday. The company has a market cap of $26.80 billion, a PE ratio of 31.42, a price-to-earnings-growth ratio of 2.78 and a beta of 1.43. The stock’s 50 day simple moving average is $1,301.75 and its 200-day simple moving average is $1,365.91. Mettler-Toledo International, Inc. has a 1-year low of $962.54 and a 1-year high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, beating the consensus estimate of $12.76 by $0.60. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter last year, the business posted $12.41 earnings per share. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
Mettler-Toledo International Company Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAmazon.com, Inc. $AMZN is Asset Planning Services Inc. LA ADV’s 7th Largest Position
NEXT HEADLINE »Massachusetts Financial Services Co. MA Reduces Position in Equinix, Inc. $EQIX
Key Takeaways Biogen highlights five non-tech wide moat stocks built for durable growth and market resilience.Lockheed Martin benefits from rising defense budgets, strong backlog and sustained F-35 demand globally.Mastercard gains from digital payment adoption, AI integration, and expanding revenue streams. The wide moat strategy involves investing in companies that not only lead their industries but are also strategically fortified to maintain dominance in the future. The business models of these companies possess durable competitive advantages that shield them from competitors. This strategy isn't just about recording short-term gains, but securing a portfolio of stocks that can weather economic storms and deliver stable and predictable returns.
This investment strategy focuses on companies with unique strengths such as brand recognition, patent protection, proprietary technology and network effects. These moats ensure long-term profitability and market leadership, making the companies resilient in volatile markets.
Here we recommend five non-tech Wide Moat stocks with a favorable Zacks Rank. These stocks are: Biogen Inc. (BIIB - Free Report) , Lockheed Martin Corp. (LMT - Free Report) , Northrop Grumman Corp. (NOC - Free Report) , Mastercard Inc. (MA - Free Report) and Mettler-Toledo International Inc. (MTD - Free Report) . Each of our picks carries either a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Biogen Inc.Biogen has successfully diversified its pipeline across areas like Alzheimer's, immunology and rare disease. BIIB’s spinal muscular atrophy (SMA) treatment, Spinraza (nusinersen) was the first treatment to be approved in the United States for SMA. Despite increasing competition, Spinraza has held a decent share in most markets.
BIIB’s Leqembi/lecanemab gained approval for early Alzheimer’s disease in the United States in 2023. Though the Leqembi launch was slow, it picked up in 2024 and 2025. Leqembi has also been launched in Japan, China, the EU and some other countries. Leqembi commands over 60% of the anti-amyloid therapy market share in the United States.
BIIB is making significant progress toward building a multi-franchise portfolio through both internal development and collaborations. BIIB is expanding its pipeline portfolio into rare diseases, immunology and neuropsychiatry.
Biogen has an expected revenue and earnings growth rate of -4.7% and 3.2%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Lockheed Martin Corp.Lockheed Martin’s broad product offerings allow it to secure major defense contracts, which in turn boost its backlog count. LMT remains the largest U.S. defense contractor with a steady order flow from the Pentagon and other allies of the country.
Apart from enjoying a strong forte on the domestic front, LMT’s products are well-acclaimed in the international market. Increasing U.S. defense budget funding should boost its business. LMT continues to witness international interest in the Aegis Ballistic Missile Defense System (Aegis) from international customers, such as Japan, Spain, the Republic of Korea and Australia.
The production of F-35 jets is expected to continue for many years, given the government's current inventory target of 2,470 aircraft for the Air Force, Marine Corps and Navy by 2040 and LMT expecting the global fleet to reach more than 3,500. Consequently, one may expect LMT to witness more order inflows for F-35 in the coming days, which should significantly bolster this defense contractor’s top line.
Lockheed Martin has an expected revenue and earnings growth rate of 5.5% and 29.5%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Northrop Grumman Corp.Northrop Grumman boasts a solid presence in Defense and Cyber Security programs, with its product line being well-positioned in high-priority categories. NOC witnesses strong demand for its products across the globe. NOC boasts a strong financial position.
The current U.S. government’s inclination toward strengthening the nation’s defense system should benefit NOC. Foreign military sales also serve as a key growth catalyst for Northrop, with the company delivering its products and services to customers in 25 nations. NOC’s international sales totaled $5.99 billion in 2025, comprising 14% of total sales, and improving a solid 19.8% year over year.
Northrop Grumman has an expected revenue and earnings growth rate of 4.6% and 6.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Mastercard Inc.Mastercard’s acquisitions are helping it to increase addressable markets and drive new revenue streams. MA’s net revenue rose16% year over year in 2025. The accelerated adoption of digital and contactless solutions is providing an opportunity for MA’s business to expedite its shift to the digital mode. Strong cash flow supports its growth initiatives.
Mastercard is aggressively adopting AI technologies to enhance security and customer experiences. MA is using AI in five different aspects of its operations — first, fraud detection and prevention, second, optimization of the payment processing services, third, customer experience personalization, fourth, deeper analysis of customer behavior using predictive AI analytics tools and finally the use of high-end AI technologies to enhance merchant services.
Mastercard has an expected revenue and earnings growth rate of 12.7% and 14.8%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.01% in the last seven days.
Mettler-Toledo International Inc.Mettler-Toledo is benefiting from its innovative product portfolio, strong demand for automation solutions and market share gains in product inspection. MTD’s expanded midrange product offerings have attracted new customers, while its bioprocessing-related sales remain strong, supported by unique workflow solutions.
MTD offered positive 2026 guidance, with operating margin expected to be up 60 to 70 basis points, which is flattish to slightly up on a reported basis. Strong liquidity is expected to help MTD continue its share repurchase program. Free cash flow is expected to be approximately $900 million in 2026, representing a 5% increase on a per share basis, with the first quarter expected to be approximately $100 million.
Mettler-Toledo International has an expected revenue and earnings growth rate of 4.9% and 8.9%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced first quarter results for 2026. Provided below are the highlights:
Reported sales increased 7% compared with the prior year. In local currency, sales increased 3% compared with the prior year reflecting an increase of 1% excluding acquisitions. Net earnings per diluted share as reported (EPS) were $8.33, compared with $7.81 in the prior-year period. Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results
Patrick Kaltenbach, President and Chief Executive Officer, stated, “We are pleased with our first quarter results as we delivered good performance in an increasingly uncertain market environment. Solid execution of our margin initiatives supported very good Adjusted EPS growth.”
GAAP Results
EPS in the quarter was $8.33, compared with the prior-year amount of $7.81.
Compared with the prior year, total reported sales increased 7% to $947.1 million. By region, reported sales increased 3% in the Americas, 12% in Europe, and 8% in Asia/Rest of World. Earnings before taxes amounted to $209.7 million, compared with $201.9 million in the prior year.
Non-GAAP Results
Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19.
Compared with the prior year, total sales in local currency increased 3%. By region, local currency sales increased 2% in the Americas, 1% in Europe, and 5% in Asia/Rest of World. Excluding acquisitions, first quarter local currency sales increased 1%, including flat sales in the Americas and 3% growth in Asia/Rest of World. Adjusted Operating Profit amounted to $246.2 million, compared with the prior-year amount of $236.7 million.
Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
Outlook
Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the second quarter of 2026 will increase approximately 3%. Adjusted EPS is forecast to be $10.70 to $10.85, a growth rate of 6% to 8%.
For the full year 2026, management anticipates local currency sales will increase approximately 4%. Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%. This compares with previous local currency sales growth guidance of approximately 4% and Adjusted EPS guidance of $46.05 to $46.70.
The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.
Conclusion
Kaltenbach concluded, “Our investments in innovation continue to provide tangible benefits and also position us strongly to capitalize on our customers’ investments in automation, digitalization, and onshoring in the future. While we recognize increased uncertainty in the macroeconomic environment, we remain confident in our agility and the strong execution of our growth and margin expansion programs to achieve solid Adjusted EPS growth this year.”
Other Matters
The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, May 8) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company’s website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Forward-Looking Statements Disclaimer
You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” or “continue.”
We make forward-looking statements in this Quarterly Report about future events or our future financial performance, including sales and earnings growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, share repurchases, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, the conflict in Ukraine and continuing instability in the Middle East on our business.
Our forward-looking statements may not be accurate or complete, speak only as of the date of this Quarterly Report, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, inflation, the conflict in Ukraine and continuing instability in the Middle East. See in particular “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2025 and other reports filed with the SEC from time to time.
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) Three months ended Three months ended March 31, 2026 % of sales March 31, 2025 % of sales Net sales $947,127
(a) 100.0
$883,744
(a) 100.0
Cost of sales 391,311
41.3
357,865
40.5
Gross profit 555,816
58.7
525,879
59.5
Research and development 51,275
5.4
46,346
5.2
Selling, general and administrative 258,326
27.3
242,799
27.5
Amortization 19,612
2.1
17,193
2.0
Interest expense 17,007
1.8
16,653
1.9
Restructuring charges 7,270
0.8
3,767
0.4
Other charges (income), net (7,329)
(0.8)
(2,821)
(0.3)
Earnings before taxes 209,655
22.1
201,942
22.8
Provision for taxes 40,201
4.2
38,355
4.3
Net earnings $169,454
17.9
$163,587
18.5
Basic earnings per common share: Net earnings $8.35
$7.84
Weighted average number of common shares 20,286,133
20,868,873
Diluted earnings per common share: Net earnings $8.33
$7.81
Weighted average number of common and common equivalent shares 20,338,274
20,945,188
Note: (a) Local currency sales increased 3% as compared to the same period in 2025.
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT Three months ended Three months ended March 31, 2026 % of sales March 31, 2025 % of sales Earnings before taxes $209,655
$201,942
Amortization 19,612
17,193
Interest expense 17,007
16,653
Restructuring charges 7,270
3,767
Other charges (income), net (7,329)
(2,821)
Adjusted operating profit $246,215
(b) 26.0
$236,734
26.8
Note: (b) Adjusted operating profit increased 4% as compared to the same period in 2025.
METTLER-TOLEDO INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
(unaudited)
March 31, 2026 December 31, 2025 Cash and cash equivalents $60,574
$66,888
Accounts receivable, net 708,206
778,243
Inventories 404,826
387,228
Other current assets and prepaid expenses 158,305
130,308
Total current assets 1,331,911
1,362,667
Property, plant and equipment, net 830,329
845,636
Goodwill and other intangibles assets, net 1,010,637
1,018,135
Other non-current assets 496,038
486,208
Total assets $3,668,915
$3,712,646
Short-term borrowings and maturities of long-term debt $67,042
$63,931
Trade accounts payable 228,719
266,628
Accrued and other current liabilities 812,600
867,557
Total current liabilities 1,108,361
1,198,116
Long-term debt 2,161,596
2,088,241
Other non-current liabilities 440,841
449,925
Total liabilities 3,710,798
3,736,282
Shareholders’ equity (41,883)
(23,636)
Total liabilities and shareholders’ equity $3,668,915
$3,712,646
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (amounts in thousands) (unaudited) Three months ended March 31, 2026
2025
Cash flow from operating activities: Net earnings $169,454
$163,587
Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation 13,160
12,464
Amortization 19,612
17,193
Deferred tax provision (benefit) (1,994)
(879)
Share-based compensation 5,469
5,139
Proceeds from government grant (a) 6,240
-
Decrease in cash resulting from changes in operating assets and liabilities (72,147)
(3,055)
Net cash provided by operating activities 139,794
194,449
Cash flows from investing activities: Purchase of property, plant and equipment (17,414)
(17,255)
Acquisitions (2,242)
-
Other investing activities (11,692)
10,348
Net cash used in investing activities (31,348)
(6,907)
Cash flows from financing activities: Proceeds from borrowings 513,590
512,496
Repayments of borrowings (420,104)
(479,326)
Proceeds from exercise of stock options 620
2,198
Repurchases of common stock (206,250)
(218,749)
Acquisition contingent consideration paid (2,190)
-
Other financing activities -
(764)
Net cash used in financing activities (114,334)
(184,145)
Effect of exchange rate changes on cash and cash equivalents (426)
1,532
Net increase in cash and cash equivalents (6,314)
4,929
Cash and cash equivalents: Beginning of period 66,888
59,362
End of period $60,574
$64,291
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
Three months ended March 31, 2026
2025
Net cash provided by operating activities $139,794
$194,449
Payments in respect of restructuring activities 3,436
2,566
Payments for acquisition transaction costs 137
-
Proceeds from government grant (a) (6,240)
-
Purchase of property, plant and equipment, net (17,414)
(17,255)
Adjusted free cash flow $119,713
$179,760
METTLER-TOLEDO INTERNATIONAL INC. OTHER OPERATING STATISTICS SALES GROWTH BY DESTINATION (unaudited) Americas Europe Asia/RoW
Total U.S. Dollar Sales Growth Three Months Ended March 31, 2026 3%
12%
8%
7%
Local Currency Sales Growth Three Months Ended March 31, 2026 2%
1%
5%
3%
Note: (a) Net sales in local currency excluding acquisitions grew 1%, including flat sales in the Americas and 3% sales growth in Asia/Rest of World, for the three months ended March 31, 2026. RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS (unaudited) Three months ended March 31, 2026
2025
% Growth EPS as reported, diluted $8.33
$7.81
7%
Purchased intangible amortization, net of tax 0.27
(a) 0.23
(a) Restructuring charges, net of tax 0.29
(b) 0.15
(b) Income tax expense 0.02
(c) -
Adjusted EPS, diluted $8.91
$8.19
9%
Notes: (a) Represents the EPS impact of purchased intangibles amortization of $7.1 million ($5.4 million after tax) and $6.3 million ($4.9 million after tax) for the three months ended March 31, 2026 and 2025, respectively. (b) Represents the EPS impact of restructuring charges of $7.3 million ($5.9 million after tax) and $3.8 million ($3.1 million after tax) for the three months ended March 31, 2026 and 2025, respectively, which primarily include employee related costs. (c) Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three months ended March 31, 2026 due to the timing of excess tax benefits associated with stock option exercises. More News From Mettler-Toledo International Inc.
Mettler-Toledo (MTD - Free Report) came out with quarterly earnings of $8.91 per share, beating the Zacks Consensus Estimate of $8.7 per share. This compares to earnings of $8.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +2.44%. A quarter ago, it was expected that this maker of precision instruments would post earnings of $12.76 per share when it actually produced earnings of $13.36, delivering a surprise of +4.7%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Mettler-Toledo, which belongs to the Zacks Medical - Instruments industry, posted revenues of $947.13 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.04%. This compares to year-ago revenues of $883.74 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Mettler-Toledo shares have lost about 4.8% since the beginning of the year versus the S&P 500's gain of 7.6%.
What's Next for Mettler-Toledo?While Mettler-Toledo has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Mettler-Toledo was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $11.04 on $1.03 billion in revenues for the coming quarter and $46.51 on $4.22 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the bottom 41% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, PAVmed Inc. (PAVM - Free Report) , has yet to report results for the quarter ended March 2026. The results are expected to be released on May 15.
This company is expected to post quarterly loss of $0.69 per share in its upcoming report, which represents a year-over-year change of +67.1%. The consensus EPS estimate for the quarter has been revised 82.2% higher over the last 30 days to the current level.
PAVmed Inc.'s revenues are expected to be $0.1 million, up 900% from the year-ago quarter.
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
MarketBeat Instant News Alerts Trending News All MarketBeat Instant News Alerts Sort By
Time Frame
Alert Type
Keywords
Page 1 of 324
Get 30 Days of MarketBeat All Access for Free
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
Start Your 30-Day Trial
Sign in to your free account to enjoy these benefits
In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer.
On May 18, 2026, Mettler-Toledo International Inc (MTD) shares rose 4.2%, closing at $1074.84. The stock has experienced significant volatility, trading within
